Cargando…
Effect of Early Pharmacologic Cardioversion vs. Non-early Cardioversion in the Patients With Recent-Onset Atrial Fibrillation Within 4-Week Follow-Up Period: A Systematic Review and Network Meta-Analysis
BACKGROUND: Whether early pharmacologic cardioversion is necessary for recent-onset atrial fibrillation is still controversial. Current meta-analyses were limited to evaluating the effects within 24 h without sufficient considering longer follow-up outcomes. We aimed to compare the effect of early p...
Autores principales: | Tang, Yan, Wang, Yujie, Sun, Xuejing, Shi, Yunmin, Liu, Suzhen, Jiang, Weihong, Yuan, Hong, Lu, Yao, Cai, Jingjing, Wu, Junru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9036487/ https://www.ncbi.nlm.nih.gov/pubmed/35479281 http://dx.doi.org/10.3389/fcvm.2022.843939 |
Ejemplares similares
-
Pharmacological cardioversion for atrial fibrillation and flutter
por: Cordina, J, et al.
Publicado: (2006) -
QTc Dynamics Following Cardioversion for Persistent Atrial Fibrillation
por: Younis, Arwa, et al.
Publicado: (2022) -
Electric Cardioversion vs. Pharmacological with or without Electric Cardioversion for Stable New-Onset Atrial Fibrillation: A Systematic Review and Meta-Analysis
por: Prasai, Paritosh, et al.
Publicado: (2023) -
Comparison of clinical outcomes of Ibutilide-guided cardioversion and direct current synchronized cardioversion after radiofrequency ablation of persistent atrial fibrillation
por: Liu, Xing, et al.
Publicado: (2023) -
Prediction of Successful Pharmacological Cardioversion in Acute Symptomatic Atrial Fibrillation: The Successful Intravenous Cardioversion for Atrial Fibrillation (SIC-AF) Score
por: Niederdöckl, Jan Daniel, et al.
Publicado: (2022)